Gerald Ds Ching, MD | |
15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006-7374 | |
(503) 531-3434 | |
(503) 645-4544 |
Full Name | Gerald Ds Ching |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 15455 Nw Greenbrier Pkwy, Beaverton, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679575062 | NPI | - | NPPES |
256388 | Medicaid | OR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | MD09883 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Gerald Ds Ching, MD 15455 Nw Greenbrier Pkwy, Ste 112, Beaverton, OR 97006-7374 Ph: (503) 466-1668 | Gerald Ds Ching, MD 15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006-7374 Ph: (503) 531-3434 |
News Archive
Schizophrenia is associated with increased rates and intensity of tobacco smoking. A growing body of research suggests that the relationship between schizophrenia and smoking stems, in part, from an effort by patients to use nicotine to self-medicate symptoms and cognitive impairment associated with the disease.
"Malnutrition is the root cause of the deaths of 2.6 million children each year, and the bodies and brains of 450 million more will fail to develop properly due to inadequate diet over the next 15 years unless immediate action is taken, according to a survey published Wednesday by" Save the Children, the Guardian reports.
Loyola University Chicago Stritch School of Medicine has formed a new research institute dedicated to understanding the molecular causes of cancer, autoimmune disorders, cardiovascular disease and several other illnesses.
BioMarin Pharmaceutical Inc. announced today that it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease. An investigational new drug application (IND) for BMN-701 has been submitted, investigational material has been manufactured and a Phase I/II study is expected to start in the first quarter of 2011.
› Verified 2 days ago
Douglas Joseph Hamill, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4855 Sw Western Ave, Beaverton Medical Office, Beaverton, OR 97005 Phone: 503-643-7565 | |
Dr. Luanne Nilsen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4855 Sw Western Ave, Beaverton, OR 97005 Phone: 503-643-7565 | |
Dean A Moshofsky, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006 Phone: 503-534-3434 Fax: 503-645-4544 | |
Heather M Moore, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 15455 Nw Greenbrier Pkwy, Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 Fax: 503-645-4544 | |
Thomas Jeffrey Anderson Ii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 15455 Nw Greenbrier Pkwy Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 Fax: 503-645-4544 | |
Cole Julius Nygard, Pediatrics Medicare: Medicare Enrolled Practice Location: 15455 Nw Greenbrier Pkwy Ste 111, Beaverton, OR 97006 Phone: 503-531-3434 | |
Mary Ellen Ulmer, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 15950 Sw Millikan Way, Beaverton, OR 97006 Phone: 503-646-0161 Fax: 503-643-7459 |